ID   MUG-Mel1
AC   CVCL_VV72
SY   MUG Mel1; MUGMel1; Medical University of Graz-Melanoma 1
DR   ChEMBL-Cells; CHEMBL4630709
DR   ChEMBL-Targets; CHEMBL4630715
DR   PubChem_Cell_line; CVCL_VV72
DR   Wikidata; Q95991469
RX   PubMed=29069749;
RX   PubMed=30858407;
CC   Doubling time: 32.16 +- 4.28 hours (PubMed=30858407).
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Lys1745Glu (c.5233A>G); Zygosity=Heterozygous (PubMed=30858407).
CC   Omics: SNP array analysis.
CC   Derived from site: Metastatic; Brain; UBERON=UBERON_0000955.
ST   Source(s): PubMed=30858407
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 11
ST   D18S51: 13,14
ST   D21S11: 31,31.2
ST   D3S1358: 17,18
ST   D5S818: 12
ST   D7S820: 8,11
ST   D8S1179: 13,14
ST   FGA: 21,24
ST   Penta D: 9,10
ST   Penta E: 5,12
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 8
//
RX   PubMed=29069749; DOI=10.18632/oncotarget.17823; PMCID=PMC5641092;
RA   Riedl S., Rinner B., Schaider H., Liegl-Atzwanger B., Meditz K.,
RA   Preishuber-Pflugl J., Grissenberger S., Lohner K., Zweytick D.;
RT   "In vitro and in vivo cytotoxic activity of human lactoferricin
RT   derived antitumor peptide R-DIM-P-LF11-334 on human malignant
RT   melanoma.";
RL   Oncotarget 8:71817-71832(2017).
//
RX   PubMed=30858407; DOI=10.1038/s41598-019-40570-1; PMCID=PMC6411871;
RA   Heitzer E., Groenewoud A., Meditz K., Lohberger B.,
RA   Liegl-Atzwanger B., Prokesch A., Kashofer K., Behrens D., Haybaeck J.,
RA   Kolb-Lenz D., Koefeler H., Riedl S., Schaider H., Fischer C.,
RA   Snaar-Jagalska B.E., de Jong D., Szuhai K., Zweytick D., Rinner B.;
RT   "Human melanoma brain metastases cell line MUG-Mel1, isolated clones
RT   and their detailed characterization.";
RL   Sci. Rep. 9:4096-4096(2019).
//